Interactions between Plasmodium falciparum–infected red blood cells and their extracellular vesicles with megakaryocytes: implications for platelet-like particle formation Authors: Nuntiporn Nunthanasup, Attakorn Palasuwan, Duangdao Palasuwan, Valery Combes Published: 2025 ABSTRACT BackgroundThrombocytopenia commonly accompanies Plasmodium falciparum (P. falciparum) malaria, yet the role of impaired megakaryopoiesis and platelet production remains unclear. This study examined how P. falciparum–infected red blood cells (pRBCs) and their extracellular vesicles (EVs) modulate megakaryocytic differentiation and platelet-like particle (PLP) formation.MethodsMEG-01 cell line, a human megakaryoblastic leukaemia model, was differentiated with phorbol 12-myristate 13-acetate (PMA) in the presence or absence of fetal bovine serum (FBS) and co-cultured with pRBCs, normal RBCs (nRBCs), or their EVs (nRBC-EVs/pRBC-EVs). Changes in cell phenotype, adhesion, and gene expression were analyzed by flow cytometry, confocal microscopy, and qPCR. PLP functionality was assessed by clotting assays, and cytokine secretion was quantified using cytometric bead array.ResultspRBCs transiently adhered to MEG-01 cells but suppressed megakaryocytic marker expression, downregulated NOTCH3, and altered apoptosis- and stress-related genes. PLP production increased under some conditions, but clotting activity was impaired, indicating reduced functionality. In contrast, RBC-EVs, particularly pRBC-EVs, were internalized but induced minimal transcriptional or functional changes. Cytokine profiling revealed that pRBCs and their EVs selectively increased IL-8, RANTES, and MCP-1 levels.ConclusionsIntact pRBCs strongly inhibit megakaryocytic differentiation and disrupt PLP function through transcriptional dysregulation and inflammatory activation, whereas under our experimental conditions, RBC-EVs exert milder modulatory effects. These findings highlight defective platelet production as a novel mechanism contributing to malaria-associated thrombocytopenia.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12936-025-05743-6. Background Severe malaria, primarily caused by Plasmodium falciparum (P. falciparum), remains a major cause of morbidity and mortality in tropical regions. Thrombocytopenia is one of the most consistent haematological manifestations of malaria and is associated with increased bleeding risk, disease severity, and poor clinical outcomes [1, 2]. The mechanisms underlying malaria-induced thrombocytopenia are multifactorial and include platelet destruction, splenic sequestration, and potentially impaired platelet production in the bone marrow (BM) [2–4]. However, the contribution of defective megakaryopoiesis, the process by which megakaryocytes (MKs) mature and release platelets, remains insufficiently understood [5, 6]. Disruption of MK differentiation or platelet formation could therefore play a key role in the observed platelet depletion during malaria infection. EVs are nanosize, membrane-bound particles released by virtually all cell types and are increasingly recognized as important mediators of intercellular communication and immune modulation [7, 8]. In malaria, pRBC-EVs contribute to host–parasite interactions and disease pathogenesis [9–11]. These vesicles can transfer parasite components, including proteins and RNA, to host cells, thereby influencing immune responses, inflammation, and vascular function [12–16]. Elevated levels of circulating pRBC-EVs have been reported in malaria patients and correlate with disease severity and immune activation [12, 17–19]. Importantly, EVs have been shown to stimulate cytokine release from monocytes and endothelial cells, promoting systemic inflammation [16]. Experimental evidence also suggests that these vesicles may affect haematopoietic and megakaryocytic processes within the BM [20], yet their specific role in regulating MK maturation and platelet biogenesis remains poorly defined. Megakaryopoiesis and platelet production are tightly regulated by cytokines and signalling pathways, including thrombopoietin, interleukins, and stem cell factor [21, 22]. Pathways such as Notch signalling and platelet-derived growth factor (PDGF) receptor signalling are also essential for MK maturation and platelet release [23, 24]. Disruption of these pathways during malaria infection could therefore lead to defective thrombopoiesis. Moreover, both platelet activation and inflammatory cytokine imbalance have been implicated in the haematological abnormalities associated with severe malaria [4, 25–27]. The MEG-01 cell line, a human megakaryoblastic leukaemia model, provides a robust in vitro system for studying megakaryocytic differentiation and PLP formation [28]. Using this model, we investigated the effects of pRBCs and their EVs on MK maturation and PLP generation. We optimized differentiation conditions using PMA and FBS to enhance PLP formation, and subsequently co-cultured MEG-01 cells with pRBCs or pRBC-EVs to assess their impact on megakaryocytic phenotype, gene expression, cytokine secretion, and PLP functionality. In summary, this study explores how P. falciparum infection and its associated EVs modulate MK differentiation and platelet production. We demonstrate that intact pRBCs, more than their EV counterparts, inhibit megakaryocytic maturation and impair PLP functionality, providing mechanistic insight into the pathogenesis of malaria-associated thrombocytopenia. Methods Maintenance of the MEG-01 cell line The human megakaryoblastic cell line MEG-01 (Merck Life Science, Australia) was maintained in RPMI-1640 medium (Thermo Fisher Scientific, USA) supplemented with 10% heat-inactivated FBS. Cells were cultured at 37 °C in a humidified incubator with 5% CO₂. For subculture, cells were gently detached using a 2.5-cm cell scraper (Sarstedt, Inc., Newton, NC, USA). For morphological assessment, 22-mm2 glass coverslips were placed in 6-well plates, and MEG-01 cells were seeded at 5 × 105 cells/ml. Differentiation and generation of PLPs To induce megakaryocytic differentiation and evaluate PLP formation, MEG-01 cells were cultured with or without FBS and stimulated with or without 50 ng/ml PMA (EMD Millipore Corporation, USA) under four conditions: + FBS/− PMA, − FBS/− PMA, − FBS/+ PMA, and + FBS/+ PMA. PMA is a potent activator of protein kinase C (PKC) that promotes megakaryocytic maturation, adhesion, and proplatelet formation, while the presence or absence of FBS allows evaluation of serum-dependent survival and differentiation cues. Cells were incubated at 37 °C for five days. Following centrifugation at 150 × g for 5 min, cells were collected, and the supernatant was centrifuged at 500 × g for 10 min to obtain PLP pellets. Both MEG-01 cells and PLPs were washed with phosphate-buffered saline (PBS) and stained with fluorochrome-conjugated antibodies against CD41a, CD42b, and CD61 (canonical megakaryocytic markers reflecting integrin αIIbβ3 and GPIb expression), Notch3 (a regulator of MK proliferation and differentiation), and Annexin V (to detect early apoptosis). These markers were chosen to evaluate both maturation and viability status during differentiation. Samples were analyzed on a CytoFLEX S flow cytometer (Beckman Coulter, USA), and PLPs were identified based on forward and side scatter profiles comparable to those of human platelets. P. falciparum culture P. falciparum 3D7 strain was maintained at 5% hematocrit in complete medium composed of RPMI-1640 supplemented with 10 μM hypoxanthine, 0.5% w/v Albumax II® (BSA lipid-rich), 10 mM D-glucose, and 20 μg/ml gentamicin. Cultures were incubated at 37 °C under a gas mixture of 5% O₂, 5% CO₂, and 90% N₂. Parasitemia was expanded to 25–30% using O⁺ human red blood cells (Australian Red Cross Lifeblood, Sydney). Although in vivo parasitemia in malaria patients is typically lower due to sequestration of mature stages in the microvasculature, high in vitro parasitemia was used to ensure sufficient interaction between pRBCs and MEG-01 cells. This approach is consistent with previous in vitro studies achieving 20–30% parasitemia for synchronized cultures [29]. After culture, samples were centrifuged at 500 × g for 5 min, and supernatants were collected for EV purification. Isolation of EVs from RBCs and pRBCs Supernatants from nRBC and pRBC cultures were centrifuged twice at 20,000 × g for 5 min to remove debris. The clarified supernatant was further ultracentrifuged twice at 150,000 × g for 90 min (Optima MAX-TL, Beckman Coulter, USA). Pellets were gently resuspended in 20–50 μl DPBS and stored at 4 °C for short-term use. All isolation steps were performed according to the MISEV 2023 guidelines to minimize contamination from protein aggregates, hemozoin, and other non-vesicular components. The number of EVs added to MEG-01 cultures was standardized across all experiments (2 × 1010 EV particles per 105 MEG-01 cells), ensuring comparable exposure regardless of the total yield obtained from RBC or pRBC preparations. Characterization of EV concentration and size Particle concentration and diameter were determined using nanoparticle tracking analysis (NTA; ZetaView QUATT, Particle Metrix, Germany). Samples were diluted in 0.2-μm filtered DPBS (1:2000–1:8000) to achieve optimal particle counts (50–200 particles/frame, sensitivity 85). Each sample was analyzed in triplicate, and 0.2-μm DPBS served as a blank control. Fluorescent labeling of EVs Purified EVs were stained with PKH26 (Sigma-Aldrich, USA) following the manufacturer’s instructions. Briefly, 250 μl of EV suspension was mixed with 1 μl PKH26 dye in 250 μl DPBS and incubated for 5 min at room temperature. Staining was quenched by adding 500 μl FBS. Samples were incubated overnight in RPMI + 10% FBS at 37 °C, centrifuged at 150,000 × g for 90 min, and resuspended in 20–50 μl DPBS. Fluorescence was confirmed by flow cytometry (PE channel, CytoFLEX S). Co-culture of MEG-01 cells with RBCs or EVs MEG-01 cells were cultured under − FBS/+ PMA or + FBS/+ PMA conditions and co-incubated with either pRBCs or their EVs to examine malaria-related effects on megakaryocytic differentiation and PLP formation. A parasitemia level of 25–30% was deliberately used to ensure sufficient exposure of MEG-01 cells to pRBCs, consistent with the culture expansion described in Sect. 2.3 and reflecting the high parasite burdens typically found within tissue microenvironments such as the BM, where sequestration leads to higher local parasite density than in circulating blood [30–32]. For co-culture, MEG-01 cells were incubated with pRBCs (25–30% parasitemia) or with 2 × 1010 EV particles per 105 MEG-01 cells for 5 days. nRBCs and nRBC-EVs served as negative controls. After incubation, both MEG-01 cells and released PLPs were collected, washed with PBS, stained with fluorochrome-conjugated antibodies, and analyzed by flow cytometry. Binding assays and imaging For fluorescence-based binding assays, MEG-01 cells were pre-stained with 1 × CellTracker™ Deep Red Dye (CTDR; Thermo Fisher Scientific, USA) for 45 min at 37 °C, while pRBCs were labeled with 5 μM Hoechst and PKH26. Co-cultures were prepared at 50 RBCs per MEG-01 cell or 2 × 1010 EVs per 105 MEG-01 cells and incubated for 5 h or overnight (~ 18 h). Binding was quantified by flow cytometry and confocal microscopy (Nikon A1R HD25, 40 × objective). For z-stack analysis, 0.25 μm optical slices were acquired and analyzed using NIS-Elements and ImageJ. Cytokine quantification Supernatants collected on days 3 and 5 were analyzed for IL-8, MIP-1α, RANTES, and MCP-1 using the BD Cytometric Bead Array (CBA) Human Soluble Protein Master Buffer Kit, following the manufacturer’s instructions (BD Biosciences, USA). Data were acquired on a BD LSRFortessa™ X-20 and analyzed using BD® CBA Analysis Software. Quantitative real-time PCR Total RNA was extracted using TRIzol (Thermo Fisher Scientific, USA) and reverse-transcribed to cDNA using iScript™ Reverse Transcription Supermix (Bio-Rad, USA). qPCR was performed using PowerUp™ SYBR™ Green Master Mix (Thermo Fisher Scientific) on a QuantStudio 12 K Flex system. Primers (Integrated DNA Technologies) for DLL4, NOTCH3, PDGFRB, BAX, BCL2, CASPASE3, CASPASE9, ATG7, MTOR, and NOX1 are listed in Table 1. Expression was normalized to GAPDH and analyzed by the 2⁻ΔΔCT method. Biological replicates: n = 3 independent experiments. Table 1List of primer sequences used for the qPCR analysisGeneForward (5′−3′)Reverse (5′−3′)Human GapdhACTGCCACCCAGAAGACTGTCCATGCCAGTGAGCTTCCHuman Notch-3TGCCTGTCTTCCTGGGTAGCGTGTTGAAGCAGGTAHuman Dll-4TCATTGCCACGGAGGTCAAAGGTGTGGAAGGGTAHuman PDGFR-βAAGAAAGTGGGCGGCTCGGTGATGTTGATGGCAHuman BaxTCAGGATGCGTCCACCAAGAAGTGTGTCCACGGCGGCAATCATCHuman Bcl-2ATCGCCCTGTGGATGACTGAGTGCCAGGAGAAATCAAACAGAGGCHuman Caspase-3GGAAGCGAATCAATGGACTCTGGGCATCGACATCTGTACCAGACCHuman Caspase-9GTTTGAGGACCTTCGACCAGCTCAACGTACCAGGAGCCACTCTTHuman Atg-7CGTTGCCCACAGCATCATCTTCCACTGAGGTTCACCATCCTTGGHuman mTORAGCATCGGATGCTTAGGAGTGGCAGCCAGTCATCTTTGGAGACCHuman Nox-1GGTTTTACCGCTCCCAGCAGAACTTCCATGCTGAAGCCACGCTT Table 1List of primer sequences used for the qPCR analysisGeneForward (5′−3′)Reverse (5′−3′)Human GapdhACTGCCACCCAGAAGACTGTCCATGCCAGTGAGCTTCCHuman Notch-3TGCCTGTCTTCCTGGGTAGCGTGTTGAAGCAGGTAHuman Dll-4TCATTGCCACGGAGGTCAAAGGTGTGGAAGGGTAHuman PDGFR-βAAGAAAGTGGGCGGCTCGGTGATGTTGATGGCAHuman BaxTCAGGATGCGTCCACCAAGAAGTGTGTCCACGGCGGCAATCATCHuman Bcl-2ATCGCCCTGTGGATGACTGAGTGCCAGGAGAAATCAAACAGAGGCHuman Caspase-3GGAAGCGAATCAATGGACTCTGGGCATCGACATCTGTACCAGACCHuman Caspase-9GTTTGAGGACCTTCGACCAGCTCAACGTACCAGGAGCCACTCTTHuman Atg-7CGTTGCCCACAGCATCATCTTCCACTGAGGTTCACCATCCTTGGHuman mTORAGCATCGGATGCTTAGGAGTGGCAGCCAGTCATCTTTGGAGACCHuman Nox-1GGTTTTACCGCTCCCAGCAGAACTTCCATGCTGAAGCCACGCTT List of primer sequences used for the qPCR analysis PLP functional assay (plasma clotting time) The functional activity of PLPs was evaluated by thrombin-induced clotting assay. Platelet-poor plasma (PPP, 0.1-μm filtered) and 25 mM CaCl₂ were mixed with PLP-containing supernatants at 37 °C. Clot formation time was recorded as the interval from mixing to fibrin gel formation. Platelet-rich plasma (PRP) and PPP served as positive and negative controls, respectively. Statistical analysis Graphs were generated using GraphPad Prism 9.5.0 and data analyzed with SPSS SigmaStat 28.0.0.0. Results are presented as mean ± SD. Comparisons between groups were performed using one-way ANOVA followed by Bonferroni post hoc tests or Student’s t-test as appropriate. Significance levels are noted with * for p < 0.05, ** for p < 0.01, *** for p < 0.005, and **** for p < 0.001, whereas # p < 0.05, ## p < 0.01, ### p < 0.005, and #### p < 0.001 indicate comparisons within the same condition but on different days. Ethics approval All procedures complied with the Declaration of Helsinki and ICH-GCP guidelines. Ethical approval was obtained from the Chulalongkorn University Ethical Review Committee (COA No. 186/67), the University of Technology Sydney Human Research Ethics Committee (ETH20-5280), and the Australian Red Cross Lifeblood Ethics Committee (ETH24-9504). Human blood products were obtained from de-identified donations; written informed consent was not required under the approved protocols. Results Experimental design for PLP generation from MEG-01 cells and validation of RBC-EVs MEG-01 cells were cultured under four differentiation conditions (+ FBS/− PMA, − FBS/− PMA, − FBS/+ PMA, + FBS/+ PMA) to identify optimal parameters for PLP generation. Surface marker expression, PLP yield, clotting function, and cytokine secretion were analyzed on days 3 and 5. Following optimization, MEG-01 cells were co-cultured with either nRBCs or pRBCs (25–30% parasitemia) and their corresponding EVs to assess malaria-related effects (Fig. 1a). The integrity of isolated EVs was confirmed by PKH26 staining and flow cytometry (PBS blank), showing clear PKH26-positive populations and strong linearity across serial dilutions (R2 = 0.9976 for nRBC-EVs; R2 = 0.9982 for pRBC-EVs; Additional file 1, Fig. S1a–b). NTA indicated mean diameters of 171.8 ± 6.1 nm (median 156.3 ± 7.9 nm) for nRBC-EVs and 162.2 ± 26.4 nm (median 149.1 ± 18.2 nm) for pRBC-EVs (Additional file 1, Fig. S1c). The average yield was in the range of 1011 particles/mL for both EV types (Additional file 1, Fig. S1d). Overall, these data confirm successful EV recovery and establish the experimental framework for downstream co-culture assays.Fig. 1Adherence of MEG-01 cells under different culture conditions and binding interactions between MEG-01 cells and RBCs. a Schematic diagram representing PLP production from MEG-01 and co-culture with nRBCs, pRBCs, nRBC-EVs, or pRBC-EVs, followed by the collection of constituents for subsequent testing. b, d, f Phase-contrast images of MEG-01 cells on days 3 and 5 under various culture conditions. b MEG-01 cells were cultured with or without FBS and PMA. Floating cells are marked by black arrows, adherent cells by white arrows, and PLPs by circles. Scale bar: 100 µm (20 ×). d, f Co-culture of MEG-01 cells with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions, respectively. White triangles indicate RBCs. Insets highlight direct binding interactions between MEG-01 cells and RBCs. Scale bars: 200 µm (40 ×). (c, e, g) Quantification of adherent MEG-01 cells. c Percentage of adherent cells on days 3 and 5. (e, g) Ratios of adherent cells in co-cultures with nRBCs or pRBCs under − FBS/+ PMA or + FBS/+ PMA conditions, respectively. Statistical significance: **p < 0.01, ****p < 0.001 between conditions; #p < 0.05, ##p < 0.01, ####p < 0.001 within the same condition across different days; ns non-significant Adherence of MEG-01 cells under different culture conditions and binding interactions between MEG-01 cells and RBCs. a Schematic diagram representing PLP production from MEG-01 and co-culture with nRBCs, pRBCs, nRBC-EVs, or pRBC-EVs, followed by the collection of constituents for subsequent testing. b, d, f Phase-contrast images of MEG-01 cells on days 3 and 5 under various culture conditions. b MEG-01 cells were cultured with or without FBS and PMA. Floating cells are marked by black arrows, adherent cells by white arrows, and PLPs by circles. Scale bar: 100 µm (20 ×). d, f Co-culture of MEG-01 cells with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions, respectively. White triangles indicate RBCs. Insets highlight direct binding interactions between MEG-01 cells and RBCs. Scale bars: 200 µm (40 ×). (c, e, g) Quantification of adherent MEG-01 cells. c Percentage of adherent cells on days 3 and 5. (e, g) Ratios of adherent cells in co-cultures with nRBCs or pRBCs under − FBS/+ PMA or + FBS/+ PMA conditions, respectively. Statistical significance: **p < 0.01, ****p < 0.001 between conditions; #p < 0.05, ##p < 0.01, ####p < 0.001 within the same condition across different days; ns non-significant FBS and PMA synergistically increase MEG-01 adhesion; pRBCs induce a transient adhesive response while RBC-EVs have minimal effect Microscopy and quantitative analysis demonstrated that both FBS and PMA markedly promote MEG-01 adhesion and PLP release (Fig. 1b–c). The + FBS/+ PMA condition produced the highest adhesion (61.3% on day 5 vs 9.2% on day 3; ****p < 0.001, ####p < 0.001). Serum deprivation abolished adhesion irrespective of PMA. Co-culture with nRBCs or pRBCs (25–30% parasitemia) produced visible RBC binding to MEG-01 cells in both − FBS/+ PMA and + FBS/+ PMA settings (Fig. 1d, f). Under − FBS/+ PMA, pRBCs transiently increased adhesion (ratio = 2.75 on day 3; **p < 0.01) but this effect resolved by day 5 (ratio = 0.98; ##p < 0.01) (Fig. 1e). A similar transient effect occurred under + FBS/+ PMA (day 3 ratio = 2.36; ****p < 0.001 to day 5 ratio = 0.63; ####p < 0.001) (Fig. 1g). By contrast, co-incubation with nRBC-EVs or pRBC-EVs (1010 particles/105 MEG-01) produced no substantial microscopic changes in adhesion; only a minor increase with pRBC-EVs on day 5 (#p < 0.05) was observed, indicating minimal overall EV impact on adhesion (Additional file 1, Fig. S2a − c). Time-dependent interactions measured by flow cytometry: stronger overnight binding, distinct patterns for RBCs versus RBC-EVs For clarity, “RBC” refers to either nRBC or pRBC, while “RBC-EVs” denotes EVs derived from each respective source. Both adherent and floating fractions of MEG-01 cells were analyzed separately, representing attached, differentiated cells and those in suspension, less mature cells, respectively. Flow cytometry revealed time-dependent increases in MEG-01 interactions with RBCs or RBC-EVs, with differences between adherent and floating subpopulations (Fig. 2d–f; Additional file 1, Fig. S5). At 5 h, interactions were low and similar across groups. Overnight incubation markedly increased interactions for both adherent and floating cells (####p < 0.001). Adherent MEG-01 showed larger overnight increases with nRBCs (Δ = 26.13%) than with pRBCs (Δ = 10.33%), and nRBC binding exceeded pRBC binding (****p < 0.001; Fig. 2e). By contrast, EV-mediated binding behaved differently: pRBC-EVs displayed greater binding than nRBC-EVs at 5 h (adherent Δ = 2.84%; floating Δ = 2.40%) and this divergence expanded overnight (adherent Δ = 10.41%; floating Δ = 8.77%) (****p < 0.001, ####p < 0.001; Fig. 2f). Thus, intact nRBCs promote more pronounced cell–cell contact overnight, whereas pRBC-EVs show stronger vesicle-mediated engagement over time.Fig. 2Binding of RBCs and RBC-EVs to MEG-01 cells after 5 h and overnight incubation. a Confocal images showing MEG-01 cells (cytoplasm stained with CTDR; magenta) and RBCs (membrane stained with PKH26; yellow). Scale bar: 10 µm (100 ×). b Quantification of binding between CTDR-labeled MEG-01 cells and PKH26-labeled RBCs or RBC-EVs using ImageJ. Binding events were counted in 10 randomly selected fields or normalized per 1,000 adherent MEG-01 cells at 5 h and overnight. c Z-stack confocal images showing binding interactions between MEG-01 cells and either RBCs or RBC-EVs after overnight co-culture. d Flow cytometry gating of double-positive nRBCs, pRBCs, nRBC-EVs, and pRBC-EVs bound to adherent or floating MEG-01 cells. e, f Bar graphs showing the percentage of CTDR-positive adherent and floating MEG-01 cells (+ FBS/+ PMA condition) after co-incubation with PKH26-labeled nRBCs/pRBCs (e) or nRBC-EVs/pRBC-EVs (f) for 5 h and overnight; n = 3. Statistical significance: ****p < 0.001 between conditions; ###p < 0.005, ####p < 0.001 between time points within the same condition; ns not significant Binding of RBCs and RBC-EVs to MEG-01 cells after 5 h and overnight incubation. a Confocal images showing MEG-01 cells (cytoplasm stained with CTDR; magenta) and RBCs (membrane stained with PKH26; yellow). Scale bar: 10 µm (100 ×). b Quantification of binding between CTDR-labeled MEG-01 cells and PKH26-labeled RBCs or RBC-EVs using ImageJ. Binding events were counted in 10 randomly selected fields or normalized per 1,000 adherent MEG-01 cells at 5 h and overnight. c Z-stack confocal images showing binding interactions between MEG-01 cells and either RBCs or RBC-EVs after overnight co-culture. d Flow cytometry gating of double-positive nRBCs, pRBCs, nRBC-EVs, and pRBC-EVs bound to adherent or floating MEG-01 cells. e, f Bar graphs showing the percentage of CTDR-positive adherent and floating MEG-01 cells (+ FBS/+ PMA condition) after co-incubation with PKH26-labeled nRBCs/pRBCs (e) or nRBC-EVs/pRBC-EVs (f) for 5 h and overnight; n = 3. Statistical significance: ****p < 0.001 between conditions; ###p < 0.005, ####p < 0.001 between time points within the same condition; ns not significant Confocal microscopy confirms surface association of intact RBCs and internalization of RBC-EVs after overnight exposure Confocal imaging with z-stack analysis corroborated flow cytometry findings. Both nRBCs and pRBCs adhered to MEG-01 cells at 5 h and overnight but remained surface-associated (no internalization detected) (Fig. 2a, c; Additional file 1, Fig. S3a, c). Overnight binding increased significantly versus 5 h, and nRBCs associated more strongly than pRBCs (40.8% difference; ****p < 0.001; Fig. 2b). In contrast, nRBC-EVs and pRBC-EVs were observed both on the surface and internalized within MEG-01 cells after overnight incubation, as shown by z-stacks (Fig. 2c; Additional file 1, Fig. S3b, d). EV binding increased significantly overnight for both EV types (####p < 0.001). Similar patterns were present in floating cell fractions (Additional file 1, Fig. S4). Collectively, microscopy supports a model in which intact RBCs predominantly adhere to the MEG-01 surface, while RBC-EVs can be internalized upon prolonged exposure. Intact RBCs suppress megakaryocytic surface marker expression on MEG-01 cells; EVs exert limited effects Under PMA stimulation, particularly with FBS, MEG-01 cells upregulated canonical megakaryocytic markers (CD41a, CD42b, CD61), double-positive populations (CD41a⁺CD42b⁺, CD41a⁺CD61⁺) and Notch3 (Fig. 3a–g; Additional file 1, Figs S6a–b and S7a–g). However, co-culture with nRBCs or pRBCs under − FBS/+ PMA or + FBS/+ PMA substantially reduced expression of these markers, including double-positive subsets and Notch3, indicating that intact RBCs impair megakaryocytic maturation (Fig. 3h–n; Additional file 1, Figs S6c–d and S7h–n). Although the reduction in marker detection could partly reflect steric hindrance caused by adherent RBCs masking surface antigens, the consistent decrease across multiple markers, including Notch3, suggests true suppression of differentiation rather than a purely physical artifact. Annexin V expression remained largely unchanged across conditions, suggesting that apoptosis was not the primary driver of the observed differences. Exposure to nRBC-EVs or pRBC-EVs produced minimal changes in marker expression overall (Additional file 1, Figs S6e–f and S7o–u). The only consistent EV effect was a reduction of CD42b under − FBS/+ PMA (****p < 0.001) and modest time-dependent declines of CD41a/CD42b between days 3 and 5 in EV-treated groups (####p < 0.001). These data indicate that direct contact with intact RBCs, rather than EVs, is the primary driver of megakaryocytic marker suppression.Fig. 3Expression of surface markers on MEG-01 cells under different culture conditions and during co-culture with RBCs. Flow cytometry was used to assess surface marker expression on MEG-01 cells cultured under various conditions for 5 days. a–g Bar graphs showing the expression of CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺ double-positive cells, Notch3, and Annexin V in MEG-01 cells cultured with or without FBS and PMA; n = 4. h–n Expression of the same markers in MEG-01 cells co-cultured with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions. All marker levels are expressed as the percentage of positive MEG-01 cells; n = 4. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions; #p < 0.05, ####p < 0.001 between condition within the same treatments; ns not significant Expression of surface markers on MEG-01 cells under different culture conditions and during co-culture with RBCs. Flow cytometry was used to assess surface marker expression on MEG-01 cells cultured under various conditions for 5 days. a–g Bar graphs showing the expression of CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺ double-positive cells, Notch3, and Annexin V in MEG-01 cells cultured with or without FBS and PMA; n = 4. h–n Expression of the same markers in MEG-01 cells co-cultured with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions. All marker levels are expressed as the percentage of positive MEG-01 cells; n = 4. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions; #p < 0.05, ####p < 0.001 between condition within the same treatments; ns not significant pRBCs reduce megakaryocytic marker expression on MEG-01-derived PLPs; EVs have negligible influence PLPs harvested from MEG-01 cultures under ± FBS and ± PMA exhibited expected platelet marker expression when differentiated (Fig. 4a–g; Additional file 1, Figs S8a–b and S9a–g). Co-culture with pRBCs produced a pronounced reduction in PLP surface markers under both − FBS/+ PMA and + FBS/+ PMA, consistent with impaired PLP maturation (Fig. 4h–n; Additional file 1, Figs S8c–d and S9h–n). Notably, Notch3 was reduced in PLPs on day 3 under + FBS/+ PMA when co-cultured with either pRBCs or nRBCs; Annexin V did not differ across groups. Co-culture with nRBC-EVs or pRBC-EVs elicited no significant changes in PLP marker profiles (Additional file 1, Figs S8e–f and S9o–u). Thus, intact pRBCs suppress phenotypic maturation of released PLPs, whereas EVs exert little effect.Fig. 4Expression of surface markers on PLPs derived from MEG-01 cells under different culture conditions and during co-culture with RBCs. Flow cytometry was used to assess the expression of surface markers on PLPs collected from MEG-01 cultures for 5 days. a–g Bar graphs showing the expression of CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺ double-positive cells, Notch3, and Annexin V in PLPs generated with or without FBS and PMA stimulation; n = 4. h–n Expression of the same markers in PLPs derived from MEG-01 cells co-cultured with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions; n = 4. All values represent the percentage of marker-positive PLPs. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions; ##p < 0.01, ###p < 0.005, ####p < 0.001 between condition within the same treatments; ns not significant Expression of surface markers on PLPs derived from MEG-01 cells under different culture conditions and during co-culture with RBCs. Flow cytometry was used to assess the expression of surface markers on PLPs collected from MEG-01 cultures for 5 days. a–g Bar graphs showing the expression of CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺ double-positive cells, Notch3, and Annexin V in PLPs generated with or without FBS and PMA stimulation; n = 4. h–n Expression of the same markers in PLPs derived from MEG-01 cells co-cultured with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions; n = 4. All values represent the percentage of marker-positive PLPs. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions; ##p < 0.01, ###p < 0.005, ####p < 0.001 between condition within the same treatments; ns not significant pRBCs increase PLP yield but impair PLP clotting function under optimized conditions PLP counts (per 5 × 105 MEG-01 cells) varied with culture conditions and co-culture components (Fig. 5a–c). On day 3, − FBS cultures produced fewer PLPs than + FBS/− PMA controls, whereas + FBS/+ PMA yielded comparable counts to controls. By day 5, PLP numbers increased in all groups (day effect, ####p < 0.001; Fig. 5a). Co-culture with pRBCs increased PLP yield under − FBS/+ PMA and + FBS/+ PMA on both days (Fig. 5b). pRBC-EVs modestly increased PLP counts at day 5 under + FBS/+ PMA but had little effect under − FBS/+ PMA (Fig. 5c). Functionally, PLPs shortened clotting time relative to PPP (negative control) on day 3 and approached PRP (positive control) by day 5, indicating functional competency (Fig. 5d). However, PLPs generated in the presence of pRBCs exhibited significantly prolonged clotting times compared with nRBCs and controls (****p < 0.001) in both − FBS/+ PMA and + FBS/+ PMA conditions (Fig. 5e), indicating that pRBC exposure reduces PLP procoagulant function despite sometimes increasing PLP numbers. pRBC-EVs increased PLP counts without measurably altering clotting times.Fig. 5Production and functional activity of PLPs derived from MEG-01 cells under different culture conditions and during co-culture with RBCs or RBC-EVs. PLPs were collected from culture supernatants by centrifugation at 500 × g for 10 min and counted using a Malassez chamber. a Bar graph showing the number of PLPs per 500,000 MEG-01 cells on days 3 and 5 under different culture conditions; n = 3. b PLP counts from MEG-01 cells co-cultured with nRBCs or pRBCs with or without FBS and PMA; n = 3. c Similar analysis for co-cultures with nRBC-EVs or pRBC-EVs; n = 3. d Clotting activity of PLPs expressed as percentage of clotting time relative to platelet-poor plasma (PPP; negative control) and platelet-rich plasma (PRP; positive control) on days 3 and 5; n = 6. e Clotting time of PLPs produced with nRBCs or pRBCs was compared between − FBS/+ PMA and + FBS/+ PMA conditions; n = 6. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions; #p < 0.05, ###p < 0.005, ####p < 0.001 within the same condition; ns not significant Production and functional activity of PLPs derived from MEG-01 cells under different culture conditions and during co-culture with RBCs or RBC-EVs. PLPs were collected from culture supernatants by centrifugation at 500 × g for 10 min and counted using a Malassez chamber. a Bar graph showing the number of PLPs per 500,000 MEG-01 cells on days 3 and 5 under different culture conditions; n = 3. b PLP counts from MEG-01 cells co-cultured with nRBCs or pRBCs with or without FBS and PMA; n = 3. c Similar analysis for co-cultures with nRBC-EVs or pRBC-EVs; n = 3. d Clotting activity of PLPs expressed as percentage of clotting time relative to platelet-poor plasma (PPP; negative control) and platelet-rich plasma (PRP; positive control) on days 3 and 5; n = 6. e Clotting time of PLPs produced with nRBCs or pRBCs was compared between − FBS/+ PMA and + FBS/+ PMA conditions; n = 6. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions; #p < 0.05, ###p < 0.005, ####p < 0.001 within the same condition; ns not significant Effects of serum, PMA, and RBC co-culture on gene expression: dynamic regulation of differentiation, apoptosis, and stress pathways We profiled expression of 10 genes implicated in MK differentiation, apoptosis, and cellular stress on day 5 (DLL4, NOTCH3, PDGFRB, BAX, BCL2, CASPASE3, CASPASE9, ATG7, MTOR, NOX1; Fig. 6; Additional file 1, Figs S10–S11). Across baseline conditions, serum deprivation and absence of PMA modulated these transcripts in a context-dependent manner. PMA exposure tended to induce apoptotic markers (CASPASE3/9) and alter stress-related genes, whereas absence of PMA (and in some cases − FBS) was associated with higher DLL4, PDGFRB, and NOX1 in specific comparisons. (Fig. 6a–j; Additional file 1, Fig. S10a–j). Co-culture with intact nRBCs or pRBCs produced marked transcriptional changes: overall, several differentiation- and stress-related genes (including DLL4, PDGFRB, and NOX1) were substantially altered relative to + FBS/− PMA baseline, with many comparisons showing decreased expression by day 5 after co-culture (Fig. 6k–t; Additional file 1, Fig. S10k–t). NOTCH3 responses were context-dependent: modest elevations occurred under some co-culture conditions, whereas pRBC co-culture in + FBS/+ PMA reduced NOTCH3 relative to + FBS/+ PMA alone. Apoptosis-related transcripts (BAX, CASPASE9) showed transient increases under − FBS/+ PMA but were often attenuated after prolonged co-culture with pRBCs. ATG7 and MTOR displayed modest, condition-dependent regulation, with some elevation in nRBC co-cultures consistent with metabolic adaptation. Overall, intact RBCs exert stronger and more sustained transcriptional modulation than RBC-EVs. RBC-EVs induced only minor and transient transcriptional changes: several genes (NOTCH3, CASPASE9, and others) were modestly reduced at early time points in + FBS/+ PMA + EV co-culture (Additional file 1, Fig. S11a–j), but most effects resolved by day 5. Thus, EVs exert substantially weaker transcriptional influence than intact RBCs.Fig. 6Gene expression in MEG-01 cells under different culture conditions and during co-culture with RBCs. Relative gene expression in MEG-01 cells was analyzed on day 5 under various conditions, with or without FBS and PMA stimulation, and during co-culture with RBCs. a–j Bar graphs showing expression of key genes in MEG-01 cells cultured under four conditions: DLL4 (a), which impairs terminal megakaryocytic differentiation; NOTCH3 (b), a proliferation regulator; PDGFRB (c), associated with platelet function; BAX (d) and BCL2 (e), apoptosis regulators; CASPASE3 (f) and CASPASE9 (g), pro-apoptotic markers; ATG7 (h), MTOR (i), and NOX1 (j), related to autophagy and oxidative stress. k–t Expression of the same genes in MEG-01 cells co-cultured with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions; n = 3. Gene expression was quantified by RT-PCR and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Data are expressed as relative fold changes, with + FBS/− PMA set to 1. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions Gene expression in MEG-01 cells under different culture conditions and during co-culture with RBCs. Relative gene expression in MEG-01 cells was analyzed on day 5 under various conditions, with or without FBS and PMA stimulation, and during co-culture with RBCs. a–j Bar graphs showing expression of key genes in MEG-01 cells cultured under four conditions: DLL4 (a), which impairs terminal megakaryocytic differentiation; NOTCH3 (b), a proliferation regulator; PDGFRB (c), associated with platelet function; BAX (d) and BCL2 (e), apoptosis regulators; CASPASE3 (f) and CASPASE9 (g), pro-apoptotic markers; ATG7 (h), MTOR (i), and NOX1 (j), related to autophagy and oxidative stress. k–t Expression of the same genes in MEG-01 cells co-cultured with nRBCs or pRBCs under − FBS/+ PMA and + FBS/+ PMA conditions; n = 3. Gene expression was quantified by RT-PCR and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Data are expressed as relative fold changes, with + FBS/− PMA set to 1. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions Distinct regulation of inflammatory cytokines by RBCs and RBC-EVs in PMA-stimulated MEG-01 cultures Cytokine profiling (IL-8, MIP-1α, MCP-1, RANTES) revealed that PMA stimulation, particularly in + FBS/+ PMA, elevates pro-inflammatory cytokine secretion compared with + FBS/− PMA (Fig. 7a–d; Additional file 1, Fig. S12a–d). Co-culture with nRBCs and pRBCs further increased IL-8, MIP-1α, MCP-1, and RANTES on day 3 versus − FBS/+ PMA controls, with some reductions by day 5 (Fig. 7e–h; Additional file 1, Fig. S12e–h). EV addition produced selective cytokine modulation: under − FBS/+ PMA, both nRBC-EVs and pRBC-EVs increased cytokine levels on day 3; under + FBS/+ PMA, only MCP-1 remained elevated with EVs. By day 5, EV-driven differences were modest (Fig. 7i–l; Additional file 1, Fig. S12i–l). Collectively, intact RBCs induce a robust but transient cytokine response in differentiating MEG-01 cells, whereas RBC-EVs produce milder, more selective cytokine changes.Fig. 7Cytokine profiling in MEG-01 cultures under different conditions and during co-culture with RBCs or RBC-EVs. Cytokine concentrations were measured in MEG-01 culture supernatants collected on day 3 under various conditions. a–d Bar graphs showing concentrations of human IL-8 (a), MIP-1α (b), RANTES (c), and MCP-1 (d) under different culture conditions. e–h Cytokine levels in cultures co-incubated with nRBCs or pRBCs in the presence or absence of FBS and PMA. i–l Cytokine levels in cultures co-incubated with nRBC-EVs or pRBC-EVs under the same conditions; n = 6. All values represent cytokine concentrations (pg/ml). Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions Cytokine profiling in MEG-01 cultures under different conditions and during co-culture with RBCs or RBC-EVs. Cytokine concentrations were measured in MEG-01 culture supernatants collected on day 3 under various conditions. a–d Bar graphs showing concentrations of human IL-8 (a), MIP-1α (b), RANTES (c), and MCP-1 (d) under different culture conditions. e–h Cytokine levels in cultures co-incubated with nRBCs or pRBCs in the presence or absence of FBS and PMA. i–l Cytokine levels in cultures co-incubated with nRBC-EVs or pRBC-EVs under the same conditions; n = 6. All values represent cytokine concentrations (pg/ml). Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001 between conditions Discussion Thrombocytopenia is a well-recognized hematologic complication of P. falciparum malaria and frequently correlates with disease severity and poor clinical outcomes [2, 30]. While peripheral platelet consumption, splenic sequestration, and immune-mediated destruction are established contributors [4, 25], our findings suggest an additional mechanism: the suppression of megakaryopoiesis and platelet production by pRBCs and their EVs. Using the MEG-01 model, we demonstrated that intact pRBCs markedly inhibit megakaryocytic differentiation and impair PLP function, whereas RBC-EVs exert only modest and transient effects. These results highlight a dual mechanism in malaria-associated thrombocytopenia, defective platelet production in addition to peripheral consumption. Optimization experiments revealed that MEG-01 cells cultured with PMA and FBS exhibit enhanced adhesion, maturation, and PLP release. PMA serves as a potent activator of PKC, driving megakaryocytic differentiation and proplatelet formation [33–35], while FBS provides essential growth and adhesion factors that support survival and maturation [36, 37]. These conditions were incorporated into the experimental design to evaluate how infected erythrocytes and their EVs might disrupt both survival-dependent and signalling-driven maturation pathways. Notably, serum-free conditions were included to mimic nutrient-limited environments, as serum deprivation is known to induce apoptosis and stress responses in hematopoietic progenitors. Although some studies have explored serum-free megakaryopoiesis [38, 39], FBS supplementation remains essential for optimal PLP yield in MEG-01 cultures. Interestingly, co-culture with pRBCs led to an apparent paradox: an increased number of PLPs but with diminished functionality. This phenomenon may represent a stress-induced or abortive differentiation process rather than efficient thrombopoiesis. Supporting this, gene expression analysis revealed upregulation of autophagy-related ATG7, imbalance between pro- and anti-apoptotic genes (BAX/BCL2), and activation of metabolic stress regulators such as MTOR and NOX1. These findings are consistent with reports that oxidative and apoptotic stress can drive premature release of immature platelets with reduced hemostatic potential [39, 40]. The relatively high parasitemia level (25–30%) employed in this study was intentional. In vivo, peripheral parasitemia typically underestimates the true parasite burden because mature infected erythrocytes sequester in microvascular and BM compartments, where densities are markedly higher than in circulation [31, 32, 41]. Thus, the chosen parasitemia more accurately reflects these tissue conditions and ensures robust exposure of MEG-01 cells to parasite-derived factors. This also guarantees that a large proportion of EVs in pRBC cultures originate from infected cells, carrying surface and molecular signatures representative of their parasitic origin. It is also possible that pRBC-EVs in this study exerted limited effects because their molecular cargo, particularly virulence-associated proteins, may differ from those found in microvesicles generated in vivo or during later parasite stages. This could explain their minimal impact compared to intact pRBCs, which directly contact and suppress megakaryocytic differentiation. Mechanistically, we observed transient activation of the Notch signalling pathway, particularly through Notch3, in MEG-01 cells early after exposure to pRBCs. Notch signalling is known to govern MK lineage commitment and proplatelet formation [23, 42]. The early but unsustained activation of NOTCH3 suggests that pRBC exposure may trigger an initial differentiation cue followed by signalling disruption, resulting in incomplete maturation. In contrast, RBC-EVs elicited only mild or transient modulation of Notch3 expression, reinforcing that direct cellular interactions, rather than vesicular cargo, are the dominant modulators of megakaryocytic signalling. Confocal imaging further demonstrated that both nRBCs and pRBCs adhered to MEG-01 cells, yet only EVs were internalized. Notably, nRBCs exhibited stronger physical binding but caused minimal suppression of differentiation, suggesting that parasite-specific surface proteins, such as PfEMP1 or altered lipid composition, may underlie the inhibitory effect of pRBCs [8, 10, 15]. EV internalization, on the other hand, may deliver signalling molecules without triggering the same level of suppression, consistent with their limited phenotypic impact observed in this study. Cytokine profiling provided additional insight into the inflammatory context of these interactions. pRBCs induced elevated levels of IL-8 and MIP-1α, pro-inflammatory mediators linked to leukocyte recruitment and tissue damage, whereas nRBCs enhanced MCP-1 and RANTES, associated with reparative or anti-inflammatory processes [26, 27]. Such differential cytokine profiles suggest that P. falciparum infection skews megakaryocytic responses toward a pro-inflammatory state, potentially exacerbating platelet dysfunction and ineffective thrombopoiesis. Moreover, PMA itself promotes cytokine release through PKC-dependent pathways [9], which could further potentiate these inflammatory effects when combined with parasite-derived stimuli. Several limitations of this study must be acknowledged. First, the MEG-01 cell line, while valuable for modeling megakaryocytic differentiation [28, 34], may not fully replicate the behavior of primary BM MKs, particularly in terms of ploidy, morphology, and responsiveness to cytokines. Second, the in vitro system lacks the stromal, immune, and extracellular matrix components of the native BM microenvironment. Third, while our EV isolation and characterization confirmed particle size and concentration, the molecular composition of these vesicles, including specific protein, RNA, or lipid cargo, remains to be determined. In addition, the use of a single EV dose precludes evaluation of concentration-dependent effects, and our functional analyses were limited to plasma clotting assays without assessing other platelet functions such as aggregation, adhesion, or activation. Moreover, PMA provides a robust but non-physiological stimulus, which may amplify differentiation signals differently from endogenous pathways. Finally, gene expression analyses focused on a selected panel of targets, and broader transcriptional profiling would likely yield deeper mechanistic insights. Beyond these considerations, the interpretation of EV-specific effects requires further consideration. The EVs used in this study were generated under standard in vitro culture conditions for P. falciparum parasites, which do not replicate the cellular, biochemical, and mechanical complexity of the BM microenvironment. Because EV cargo composition is highly influenced by microenvironmental cues, the vesicles examined here may differ from those produced in vivo during parasite–MK interactions [43, 44]. Furthermore, EVs in this study were generated in the absence of reciprocal signalling from MKs. Although direct evidence for MK-driven modulation of RBC vesiculation is currently lacking, vesiculation of erythrocytes is known to be influenced by interactions with other cell types, such as endothelial cells and monocytes, which can alter membrane stability and promote vesicle release [45, 46]. These observations support the broader concept that heterotypic cellular interactions can regulate RBC-EV production, though the relevance of such mechanisms to MK–pRBC crosstalk remains to be determined. Lastly, a more informative approach would involve isolating EVs directly from pRBC–MEG-01 co-cultures and assessing their effects on naïve MKs to determine whether “educated” EVs contribute to suppression of megakaryopoiesis. Future investigations should aim to address these limitations by employing more physiologically relevant systems. Studies utilizing primary human MKs or induced pluripotent stem cell–derived megakaryocytic models will be critical for validating the in vitro mechanisms identified here. Systematic analysis of dose-dependent and stage-specific responses to P. falciparum–infected erythrocytes and their EVs could delineate threshold effects and dynamic signalling changes during differentiation. Implementation of EV-TRACK–compliant isolation protocols with standardized marker validation and detailed proteomic and transcriptomic profiling will enhance experimental rigor and comparability across studies. Expanding global transcriptomic analyses would also provide a comprehensive understanding of the gene networks governing differentiation, apoptosis, and stress adaptation. Lastly, in vivo models are needed to confirm whether impaired thrombopoiesis directly contributes to malaria-associated thrombocytopenia and to evaluate potential therapeutic strategies targeting megakaryocytic stress and signalling pathways. Conclusion This study indicates that pRBCs can suppress megakaryocytic maturation and reduce PLP functionality in the MEG-01 model, likely through contact-dependent effects involving dysregulated Notch-related and stress-response pathways. In contrast, RBC-EVs were internalized but exerted comparatively modest transcriptional and functional effects under the experimental conditions used. Taken together, these findings support a contributory role of impaired platelet production, alongside platelet consumption, in the development of malaria-associated thrombocytopenia. By pinpointing the signalling and stress pathways that are altered during parasite–megakaryocyte interactions, this work provides a basis for exploring strategies that modulate megakaryopoiesis or protect platelet biogenesis in the context of severe malaria. Supplementary Information Supplementary material 1. Fig. S1 Characterization of RBC-EVs. a Representative flow cytometry plots showing PKH26-positive events from isolated nRBC-EVs and pRBC-EVs; PBS served as a blank control. b Linear correlations of PKH26-positive EV count for nRBC-EVsand pRBC-EVs; n = 3. c NTA showing particle concentration, size distribution, and representative images of nRBC-EVs and pRBC-EVs; n = 3. d Scatter plot of particle concentrations for nRBC-EVs and pRBC-EVs; n = 3. Each dot represents one sample. Fig. S2 Adherence of MEG-01 cells co-cultured with RBC-EVs under different culture conditions. a Phase-contrast images of MEG-01 cells co-cultured with EVs derived from nRBCs or pRBCs on days 3 and 5 under –FBS/+PMA and +FBS/+PMA conditions, respectively. Adherent cells are indicated by white arrows. Scale bar: 200 µm,. b, c Quantification of adherent MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs under –FBS/+PMA and +FBS/+PMA conditions, respectively; n = 6. Statistical significance: #p < 0.05 indicates comparisons within the same condition across different days; ns non-significant. Fig. S3 Binding of RBCs or RBC-EVs to MEG-01 cells at 5 h and overnight, observed by fluorescence microscopy. Confocal microscopy images show the binding interactions between MEG-01 cells and RBCs or RBC-EVs after 5 h and overnight co-culture. The cytoplasm of MEG-01 cells was stained with CTDR, and RBCs were stained with PKH26. Nuclei were counterstained with DAPI. Scale bar: 10 µm,. a Binding between MEG-01 cells and either nRBCs or pRBCs. b Binding between MEG-01 cells and either nRBC-EVs or pRBC-EVs. c Z-stack images of MEG-01–RBC interactions. d Z-stack images of MEG-01–RBC-EV interactions after 5-hour and overnight co-culture. Fig. S4 Binding of RBCs or RBC-EVs to adherent and floating MEG-01 cells at 5 h and overnight, observed by fluorescence microscopy. Confocal microscopy images showing binding interactions between adherent or floating MEG-01 cells and RBCs or RBC-EVs after 5-hour and overnight co-culture. MEG-01 cytoplasm was stained with CTDR, RBCs with PKH26, and nuclei with DAPI. a Binding between adherent MEG-01 cells and either nRBCs or pRBCs. b Binding between adherent MEG-01 cells and either nRBC-EVs or pRBC-EVs. Scale bar: 10 µm,. c Binding between floating MEG-01 cells and either nRBCs or pRBCs. d Binding between floating MEG-01 cells and either nRBC-EVs or pRBC-EVs. Scale bar: 20 µm,. Fig. S5 Binding of RBCs or RBC-EVs to MEG-01 cells at 5 h and overnight, analyzed by flow cytometry. Flow cytometry gating of double-positive nRBCs, pRBCs, nRBC-EVs, and pRBC-EVs bound to adherent or floating MEG-01 cells after 5-hour and overnight incubation. CTDR; Cell Tracker Deep Red Dye. Fig. S6 Flow cytometry gating and histograms of specific surface markers on MEG-01 cells under different culture conditions, including co-culture with RBCs or RBC-EVs. a Gating strategy used for identifying MEG-01 cells and analyzing surface marker expression. b Overlay histograms showing marker expression in MEG-01 cells cultured with or without FBS/PMA on days 3 and 5. c–d Gating strategy and representative histograms for MEG-01 cells co-cultured with nRBCs or pRBCs under –FBS/+PMA and +FBS/+PMA conditions. e–f Gating strategy and histograms for MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs. All histograms include comparisons with unstained controls. Fig. S7 Changes in specific surface markers on MEG-01 cells under various culture conditions, including co-culture with RBCs or RBC-EVs, on days 3 and 5. Flow cytometry analysis of marker expression on MEG-01 cells cultured under different conditions. a–g Expression of CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺, Notch3, and Annexin V under control conditions. h–n Same markers for cells co-cultured with nRBCs or pRBCs under –FBS/+PMA and +FBS/+PMA conditions. o–u Expression of these markers in cells co-cultured with nRBC-EVs or pRBC-EVs. Data are expressed as the percentage of positive MEG-01 cells. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.005, ####p < 0.001; ns non-significant. Fig. S8 Flow cytometry gating and histograms of specific surface markers on PLPs released from MEG-01 cells under various culture conditions, including co-culture with RBCs or RBC-EVs. a Gating strategy for identifying PLPs and assessing surface marker expression. b Overlay histograms showing marker expression in PLPs cultured with or without FBS/PMA on days 3 and 5. c–d Gating strategy and histograms for PLPs from MEG-01 cells co-cultured with nRBCs or pRBCs. e–f Gating strategy and histograms for PLPs from MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs. Overlay histograms represent expression at both time points under the respective conditions. Fig. S9 Changes in specific surface markers on PLPs released from MEG-01 cells under various culture conditions, including co-culture with RBCs or RBC-EVs, on days 3 and 5. Flow cytometry analysis of surface marker expression in PLPs derived from MEG-01 cells. a–g CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺, Notch3, and Annexin V expression under control conditions. h–n Same markers for PLPs from MEG-01 cells co-cultured with nRBCs or pRBCs. o–u Expression of these markers in PLPs from MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs. All data are shown as the percentage of positive PLPs. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.005, ####p < 0.001; ns non-significant. Fig. S10 Gene expression of MEG-01 cells under various culture conditions, including co-culture with RBCs. Relative mRNA expression levels in MEG-01 cells were analyzed under different conditions, with or without FBS and PMA stimulation on day 3. a–j Expression of DLL4, NOTCH3, PDGFRB, BAX, BCL2, CASPASE3, CASPASE9, ATG7, MTOR, and NOX1. k–t Corresponding gene expression profiles in MEG-01 cells co-cultured with RBCs. Gene expression was normalized to GAPDH and expressed relative to +FBS/–PMA condition. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. Fig. S11 Gene expression of MEG-01 cells under various culture conditions, including co-culture with RBC-EVs. Relative mRNA expression levels were analyzed under different conditions with or without FBS and PMA stimulation on days 3 and 5. a–j Expression of DLL4, NOTCH3, PDGFRB, BAX, BCL2, CASPASE3, CASPASE9, ATG7, MTOR, and NOX1 after co-culture with RBC-EVs. Gene expression was normalized to GAPDH and expressed relative to +FBS/–PMA condition. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.005, ####p < 0.001. Fig. S12 Cytokine levels in supernatants under different culture conditions, including co-culture with RBCs or RBC-EVs, on day 5. a–d Concentrations of IL-8, MIP-1α, RANTES, and MCP-1 under different conditions. e–h Concentrations of the same cytokines after co-culture with nRBCs or pRBCs under ±FBS/+PMA conditions. i–l Cytokine levels after co-culture with nRBC-EVs or pRBC-EVs under ±FBS/+PMA conditions. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. Supplementary material 1. Fig. S1 Characterization of RBC-EVs. a Representative flow cytometry plots showing PKH26-positive events from isolated nRBC-EVs and pRBC-EVs; PBS served as a blank control. b Linear correlations of PKH26-positive EV count for nRBC-EVsand pRBC-EVs; n = 3. c NTA showing particle concentration, size distribution, and representative images of nRBC-EVs and pRBC-EVs; n = 3. d Scatter plot of particle concentrations for nRBC-EVs and pRBC-EVs; n = 3. Each dot represents one sample. Fig. S2 Adherence of MEG-01 cells co-cultured with RBC-EVs under different culture conditions. a Phase-contrast images of MEG-01 cells co-cultured with EVs derived from nRBCs or pRBCs on days 3 and 5 under –FBS/+PMA and +FBS/+PMA conditions, respectively. Adherent cells are indicated by white arrows. Scale bar: 200 µm,. b, c Quantification of adherent MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs under –FBS/+PMA and +FBS/+PMA conditions, respectively; n = 6. Statistical significance: #p < 0.05 indicates comparisons within the same condition across different days; ns non-significant. Fig. S3 Binding of RBCs or RBC-EVs to MEG-01 cells at 5 h and overnight, observed by fluorescence microscopy. Confocal microscopy images show the binding interactions between MEG-01 cells and RBCs or RBC-EVs after 5 h and overnight co-culture. The cytoplasm of MEG-01 cells was stained with CTDR, and RBCs were stained with PKH26. Nuclei were counterstained with DAPI. Scale bar: 10 µm,. a Binding between MEG-01 cells and either nRBCs or pRBCs. b Binding between MEG-01 cells and either nRBC-EVs or pRBC-EVs. c Z-stack images of MEG-01–RBC interactions. d Z-stack images of MEG-01–RBC-EV interactions after 5-hour and overnight co-culture. Fig. S4 Binding of RBCs or RBC-EVs to adherent and floating MEG-01 cells at 5 h and overnight, observed by fluorescence microscopy. Confocal microscopy images showing binding interactions between adherent or floating MEG-01 cells and RBCs or RBC-EVs after 5-hour and overnight co-culture. MEG-01 cytoplasm was stained with CTDR, RBCs with PKH26, and nuclei with DAPI. a Binding between adherent MEG-01 cells and either nRBCs or pRBCs. b Binding between adherent MEG-01 cells and either nRBC-EVs or pRBC-EVs. Scale bar: 10 µm,. c Binding between floating MEG-01 cells and either nRBCs or pRBCs. d Binding between floating MEG-01 cells and either nRBC-EVs or pRBC-EVs. Scale bar: 20 µm,. Fig. S5 Binding of RBCs or RBC-EVs to MEG-01 cells at 5 h and overnight, analyzed by flow cytometry. Flow cytometry gating of double-positive nRBCs, pRBCs, nRBC-EVs, and pRBC-EVs bound to adherent or floating MEG-01 cells after 5-hour and overnight incubation. CTDR; Cell Tracker Deep Red Dye. Fig. S6 Flow cytometry gating and histograms of specific surface markers on MEG-01 cells under different culture conditions, including co-culture with RBCs or RBC-EVs. a Gating strategy used for identifying MEG-01 cells and analyzing surface marker expression. b Overlay histograms showing marker expression in MEG-01 cells cultured with or without FBS/PMA on days 3 and 5. c–d Gating strategy and representative histograms for MEG-01 cells co-cultured with nRBCs or pRBCs under –FBS/+PMA and +FBS/+PMA conditions. e–f Gating strategy and histograms for MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs. All histograms include comparisons with unstained controls. Fig. S7 Changes in specific surface markers on MEG-01 cells under various culture conditions, including co-culture with RBCs or RBC-EVs, on days 3 and 5. Flow cytometry analysis of marker expression on MEG-01 cells cultured under different conditions. a–g Expression of CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺, Notch3, and Annexin V under control conditions. h–n Same markers for cells co-cultured with nRBCs or pRBCs under –FBS/+PMA and +FBS/+PMA conditions. o–u Expression of these markers in cells co-cultured with nRBC-EVs or pRBC-EVs. Data are expressed as the percentage of positive MEG-01 cells. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.005, ####p < 0.001; ns non-significant. Fig. S8 Flow cytometry gating and histograms of specific surface markers on PLPs released from MEG-01 cells under various culture conditions, including co-culture with RBCs or RBC-EVs. a Gating strategy for identifying PLPs and assessing surface marker expression. b Overlay histograms showing marker expression in PLPs cultured with or without FBS/PMA on days 3 and 5. c–d Gating strategy and histograms for PLPs from MEG-01 cells co-cultured with nRBCs or pRBCs. e–f Gating strategy and histograms for PLPs from MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs. Overlay histograms represent expression at both time points under the respective conditions. Fig. S9 Changes in specific surface markers on PLPs released from MEG-01 cells under various culture conditions, including co-culture with RBCs or RBC-EVs, on days 3 and 5. Flow cytometry analysis of surface marker expression in PLPs derived from MEG-01 cells. a–g CD41a, CD42b, CD61, CD41a⁺CD42b⁺, CD41a⁺CD61⁺, Notch3, and Annexin V expression under control conditions. h–n Same markers for PLPs from MEG-01 cells co-cultured with nRBCs or pRBCs. o–u Expression of these markers in PLPs from MEG-01 cells co-cultured with nRBC-EVs or pRBC-EVs. All data are shown as the percentage of positive PLPs. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.005, ####p < 0.001; ns non-significant. Fig. S10 Gene expression of MEG-01 cells under various culture conditions, including co-culture with RBCs. Relative mRNA expression levels in MEG-01 cells were analyzed under different conditions, with or without FBS and PMA stimulation on day 3. a–j Expression of DLL4, NOTCH3, PDGFRB, BAX, BCL2, CASPASE3, CASPASE9, ATG7, MTOR, and NOX1. k–t Corresponding gene expression profiles in MEG-01 cells co-cultured with RBCs. Gene expression was normalized to GAPDH and expressed relative to +FBS/–PMA condition. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. Fig. S11 Gene expression of MEG-01 cells under various culture conditions, including co-culture with RBC-EVs. Relative mRNA expression levels were analyzed under different conditions with or without FBS and PMA stimulation on days 3 and 5. a–j Expression of DLL4, NOTCH3, PDGFRB, BAX, BCL2, CASPASE3, CASPASE9, ATG7, MTOR, and NOX1 after co-culture with RBC-EVs. Gene expression was normalized to GAPDH and expressed relative to +FBS/–PMA condition. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.005, ####p < 0.001. Fig. S12 Cytokine levels in supernatants under different culture conditions, including co-culture with RBCs or RBC-EVs, on day 5. a–d Concentrations of IL-8, MIP-1α, RANTES, and MCP-1 under different conditions. e–h Concentrations of the same cytokines after co-culture with nRBCs or pRBCs under ±FBS/+PMA conditions. i–l Cytokine levels after co-culture with nRBC-EVs or pRBC-EVs under ±FBS/+PMA conditions. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001.